Citeline, Biomedtracker: see the drug development process th...
Catch up on any missed COVID-19 24 hour webinar sessions
Gain a deeper understanding of the implications of the Regenerative Medicine Advanced Therapies (RMAT) designation and the significance of its support and advancement by the FDA in this webinar recording, "RMAT Designation – Impact on Regenerative Medicine Sector".
Held in partnership with the Alliance for Regenerative Medicine (ARM), experts from both ARM and Informa Pharma Intelligence explored the RMAT designation and its implications.
In this recording You will gain insight into:
Datamonitor Healthcare: data analysis and insight, Biomedtra...
By Dustin Phan
The effect of COVID-19 on clinical trials, the industry response, and the return to full operations
Pharmaprojects: track pharma R&D, Biomedtracker: see the dru...
Access this infographic which focuses on Gilead’s drug Remdesivir which currently shows the greatest promise for the likelihood of approval as a possible treatment to effectively treat the virus. The infographic highlights the drug summary and profile, the number of patients in each trial phase, and the history of events that have moved this product through the development process.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: